Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

5,263

Total raised

£158B

disclosed amounts

Series A
£40.5M

Pfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.

"This financing will enable us to expand our team, progress our lead assets into the clinic and expand our drug discovery platform. We welcome our new investors alongside our existing strong syndicate and look forward to working together to take Curve to its next stage of growth."
— Simon Kerry, Chief Executive Officer
Seed
£1.7M

The funding round was led by XTX Ventures with participation from existing backers including Mercia Ventures and SFC Capital.

"Graide provides transparent, explainable AI, a requirement in today’s world, and can cover all subjects taught from school to university level, saving teacher time. We are pleased to welcome XTX Ventures, which has extensive experience in AI and machine learning, as a new investor in this round."
— Manjinder Kainth, CEO
Seed
£2.8M

The Manchester-based cybersecurity start-up has secured backing led by Nauta Capital.

"Partnering with Nauta Capital marks a significant step in our journey towards offering continuous security investment validation to enterprises. This funding is not just a financial boost but a validation of our vision at ESProfiler. It will accelerate our engineering efforts, expanding our platform's capabilities and reach."
— Louis Holt, CEO and Co-founder
Seed
£3.5M

Northern Gritstone and Parkwalk Advisors backed the seed round to support team expansion and product development.

"Medical devices follow a lengthy evaluation with a tiny amount of scientific evidence currently derived from computer modelling and simulation. The cost is ever-increasing, delaying lifesaving benefits to patients. Northern Gritstone’s and Parkwalk’s investment and support will enable adsilico to offer a scalable solution to the medical device market to produce evidence on an unprecedented scale"
— Alejandro Frangi, Founder and Chief Scientific Officer